Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €5.43B | 34.3x | 0.11 | €6.11 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols | Madrid | Healthcare | Pharmaceuticals | €5.43B | 34.3x | 0.11 | €7.94 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €2.41B | 17.8x | -1.11 | €46.94 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.94B | 181.2x | 1.55 | €9.12 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.3% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.31B | 50.4x | 0.02 | €74.95 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.15B | 10.4x | €3.70 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.4% Upside | Upgrade to Pro+ | ||
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €527.78M | 13.4x | 1.09 | €33 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €230.45M | -41.6x | €0.55 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €212.62M | -0.23 | €2.80 | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €205.75M | €2.57 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €180.54M | -46.7x | 14.06 | €2.85 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €165.06M | 15.1x | €9.70 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €57.72M | -9.9x | 0.12 | €1.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €21.16M | -6.3x | 0.03 | €0.32 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €20M | -16.4x | -0.19 | €2.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.5% Downside | Upgrade to Pro+ | |
Substrate Artificial Inteligence | Madrid | Healthcare | Healthcare Equipment & Supplies | €12.62M | -1x | €0.10 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.67M | -3.2x | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |